Medical AI Alliance
← Company Index
Healthcare InfrastructureKOSDAQ 109960

APTOCROM Inc.

Official website

Founded in 1998 and listed on KOSDAQ in 2009, APTOCROM operates pharmaceutical distribution, leasing, and insulation businesses.

Price

Change

Market cap

Products & technology

  • Pharmaceutical distribution (dermatologicals, GI drugs, etc.)Pharmaceutical distribution
  • Nuclear-plant insulation (Nukon System)Nuclear plant insulation design/manufacture/installation

R&D and key agreements

Source: DART corporate disclosure

AP063 · Trastuzumab 바이오시밀러 · 공동개발중 · Contract 2023-06-05; KRW 50B cost share; $10/vial revenue share up to 12M vials

AP096 · Adalimumab 바이오시밀러 · 공동개발중 · Contract 2024-09-19; KRW 70B cost share; $15/AI revenue share up to 8.5M AI

Key disclosures

KRX KIND via OpenDART
Show 7 more events

Patents

KIPRIS · applicant-matched
Show 25 more patents

AI reads

MAA server logs · IP-verified
17
Times AI engines pulled APTOCROM Inc.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

0
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

17
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

4
live 0
Last 7 days
11
live 0
Last 30 days
17
live 0
All time
  • OpenAIOAI-SearchBot8
  • GoogleGoogleOther5
  • AnthropicClaudeBot2
  • MicrosoftBingbot1
  • PerplexityPerplexityBot1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 2, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for APTOCROM Inc. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · regulatory approvals. Send us materials and we will add them

Companies in the same categoryHealthcare Infrastructure

CJ CHEILJEDANG CORP.100

CJ CheilJedang, founded and KOSPI-listed in 2007, operates food, BIO, and logistics businesses as a CJ Group intermediate holding company.

Kwangdong Healthbio Co., Ltd.100

Supplies red ginseng, probiotics, and other health functional foods to 300+ clients via OEM/ODM.

Cellromax Science Co., Ltd.100

Founded in 2014 and listed on KOSDAQ in 2024, Cellromax Science is a health functional food company built on a nationwide pharmacy network.

KolmarBNH Co., Ltd100

Founded and listed on KOSDAQ in 2014, KolmarBNH develops health functional food and cosmetics materials and provides ODM/OEM manufacturing.

HEM Pharma Inc.70

KOSDAQ-listed microbiome healthcare company using the PMAS gut-microbiome simulation platform and the PeachBiome028 probiotic strain.

Carelabs Co.,Ltd70

Carelabs, founded in 2012 and KOSDAQ-listed in 2018, operates mobile healthcare and beauty care platforms.

DreamCIS INC.62

Contract research organization providing clinical trial, post-marketing surveillance, and site management services to pharma and medtech clients.

S&D Co., Ltd60

Founded in 1998 and listed on KOSDAQ in 2021, S&D is a functional food ingredient company.

CosLeaguer Global Co., Ltd.60

Founded in 1991 and listed on KOSDAQ in 2002, CosLeaguer Global distributes botulinum toxin and fillers and manufactures cosmetics.

Icure Pharmaceutical Incorporation60

Founded in 2000 and listed on KOSDAQ in 2018, Icure Pharmaceutical develops TDDS drug patches and cosmetics OEM/ODM.

Bioten Co., Ltd60

Develops water-solubilized curcumin complexes for enhanced bioavailability using its WIN-T technology.

GL Pharm Tech Corp.60

Founded and listed on KOSDAQ in 2014, GL Pharm Tech is an improved-new-drug pharmaceutical R&D company.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition